- Investing Ideas
- Japanese Pharmaceuticals & Biotech Large Cap High Growth Potential
Japanese Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
3
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
3 companies
Chugai Pharmaceutical
Market Cap: JP¥12.2t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,397.00
7D
2.2%
1Y
9.1%
Takeda Pharmaceutical
Market Cap: JP¥8.8t
Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products.
4502
JP¥5,555.00
7D
4.3%
1Y
30.6%
Daiichi Sankyo Company
Market Cap: JP¥5.0t
Manufactures and sells pharmaceutical products in Japan and internationally.
4568
JP¥2,815.00
7D
5.1%
1Y
-19.4%